Recombinant human immunodeficiency virus type 1 (HIV-1) Tat protein inhibits phagolysosomal fusion in human peripheral blood monocytes

被引:1
|
作者
Pittis, MG
Prada, F
Sternik, G
Sen, L
机构
[1] Laboratorio de Biología Celular y Retrovirus, Hospital de Pediatría Juan P. Garrahan, Buenos Aires
[2] Laboratorio Biología Celular y Retrovirus, Hospital de Pediatría Juan P. Garrahan, (1245) Buenos Aires
关键词
D O I
10.1089/vim.1996.9.169
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of recombinant HIV-1 Tat protein on different functions of peripheral blood monocytes, such as candidacidal activity and phagolysosomal fusion, was evaluated. HIV-1 Tat protein caused a significant impairment of phagolysosomal fusion at 100 ng/ml (p = 0.018). The inhibitory effect of Tat on phagolysosomal fusion was blocked by the addition of 1 mu g/ml monoclonal anti-Tat antibody. Candidacidal activity of peripheral monocytes was not altered by HIV-1 Tat protein at the concentration of 1 mu g/ml. These results indicate that HIV-1 Tat protein can affect the monocyte microbicidal mechanisms at the phagolysosomal fusion step with little or not effect upon the lytic activity.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 50 条
  • [21] Korean medicinal plants inhibiting to human immunodeficiency virus type 1 (HIV-1) fusion
    Chang, YS
    Woo, ER
    PHYTOTHERAPY RESEARCH, 2003, 17 (04) : 426 - 429
  • [22] Deguanylation of human immunodeficiency virus (HIV-1) RNA by recombinant pokeweed antiviral protein
    Rajamohan, F
    Kurinov, IV
    Venkatachalam, TK
    Uckun, FM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (02) : 419 - 424
  • [23] BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA TO RECOMBINANT HIV-1 GAG POLYPROTEIN
    LUBAN, J
    GOFF, SP
    JOURNAL OF VIROLOGY, 1991, 65 (06) : 3203 - 3212
  • [24] RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TAT PROTEIN SEQUENTIALLY UP-REGULATES IL-6 AND TFG-BETA-1 MESSENGER-RNA EXPRESSION AND PROTEIN-SYNTHESIS IN PERIPHERAL-BLOOD MONOCYTES
    GIBELLINI, D
    ZAULI, G
    RE, MC
    MILANI, D
    FURLINI, G
    CARAMELLI, E
    CAPITANI, S
    LAPLACA, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) : 261 - 267
  • [25] Preferential vulnerability of glial precursors to opiates and human immunodeficiency virus-1 (HIV-1) Tat protein
    Khurdayan, VK
    Dean, CS
    Turchan, J
    Nath, A
    Hauser, KF
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 8 - 8
  • [26] RANDOM MUTAGENESIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATOR OF TRANSCRIPTION (HIV-1 TAT)
    SIDEROVSKI, DP
    MATSUYAMA, T
    FRIGERIO, E
    CHUI, S
    MIN, X
    ERFLE, H
    SUMNERSMITH, M
    BARNETT, RW
    MAK, TW
    NUCLEIC ACIDS RESEARCH, 1992, 20 (20) : 5311 - 5320
  • [27] Human immunodeficiency virus-1 Nef protein interacts with Tat and enhances HIV-1 gene expression
    Joseph, AM
    Ladha, JS
    Mojamdar, M
    Mitra, D
    FEBS LETTERS, 2003, 548 (1-3) : 37 - 42
  • [28] Functions of Tat: the versatile protein of human immunodeficiency virus type 1
    Romani, Bizhan
    Engelbrecht, Susan
    Glashoff, Richard H.
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1 - 12
  • [29] In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity
    Celeghini, C
    Marchisio, M
    Mischiati, C
    Bertolaso, L
    Capitani, S
    Zauli, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (02) : 349 - 354
  • [30] HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 (HIV-1) AND THE BRAIN
    GRANT, I
    HEATON, RK
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (01) : 22 - 30